Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 1.1T | 1.0T | 1.1T | 1.2T |
Cost of revenue | 694.2B | 622.4B | 659.1B | 869.7B |
Gross profit | 434.1B | 383.0B | 414.0B | 322.5B |
Operating expense | ||||
Research & development | 27.7B | 29.5B | 27.6B | 32.5B |
Selling general and admin | — | — | — | — |
Other operating expenses | 244.0B | 208.3B | 197.3B | -20.6B |
Operating income | -4.3B | -22.9B | 12.7B | 69.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 17.3B | 20.3B | 20.9B | 22.3B |
Other income expense | — | — | — | — |
Pretax income | 76.7B | 57.7B | 88.7B | 98.2B |
Tax provision | 21.0B | 23.2B | 31.8B | -81.6B |
Net income | 55.8B | 34.5B | 56.9B | 175.3B |
Basic EPS | 14.8 | 9.7 | 14.5 | — |
Diluted EPS | 14.8 | 9.7 | 14.5 | — |
Basic average shares | 3.7B | 3.4B | 3.8B | — |
Diluted average shares | 3.7B | 3.4B | 3.8B | — |
EBITDA | 148.3B | 138.4B | 174.9B | 205.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.3B | -1.1B | -1.3B | -1.2B |
Preferred stock dividends | 0 | 0 | 0 | 0 |